Cargando…
Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1
Vascular endothelial cell growth factor (VEGF) is a key regulator of vascular permeability. Herein we aim to understand how acute and chronic exposures of VEGF induce different levels of vascular permeability. We demonstrate that chronic VEGF exposure leads to decreased phosphorylation of VEGFR2 and...
Autores principales: | Wang, Ying, Angom, Ramcharan Singh, Kulkarni, Tanmay A., Hoeppner, Luke H., Pal, Krishnendu, Wang, Enfeng, Tam, Alexander, Valiunas, Rachael A., Dutta, Shamit K., Ji, Baoan, Jarzebska, Natalia, Chen, Yingjie, Rodionov, Roman N., Mukhopadhyay, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521174/ https://www.ncbi.nlm.nih.gov/pubmed/34703990 http://dx.doi.org/10.1016/j.isci.2021.103189 |
Ejemplares similares
-
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023) -
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
por: Pal, Krishnendu, et al.
Publicado: (2019) -
Vascular Endothelial Growth Factor Receptor-1 Modulates Hypoxia-Mediated Endothelial Senescence and Cellular Membrane Stiffness via YAP-1 Pathways
por: Angom, Ramcharan Singh, et al.
Publicado: (2022) -
Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System
por: Kozlova, Alena A., et al.
Publicado: (2021) -
Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
por: Hulin, Julie-Ann, et al.
Publicado: (2020)